Antidepressant effects of hydroalcoholic extract of Alpinia officinarum rhizome on chronic unpredictable stress induced depression in BALB/c mice by Salehi, Azadeh et al.
J. Med. Plants 2020; 19(73): 170-179 
 
 
 
Journal of Medicinal Plants 
 
 
Journal homepage: www.jmp.ir 
 
 
 
Abbreviations: MDA, malondialdehyde, CUS, chronic unpredictable stress, TCA, total antioxidant capacity; IP, 
intraperitoneal 
* Corresponding author: doctor.setorgi@gmail.com 
doi: 10.29252/jmp.1.73.170 
Received 13 July 2019; Received in revised form 8 January 2020; Accepted: 23 February 2020 
© 2020. Open access. This article is distributed under the terms of the Creative Commons Attribution 4.0 
International License (https://creativecommons.org/licenses/by-nc/4.0/) 
Research Article 
Antidepressant effects of hydroalcoholic extract of Alpinia officinarum rhizome 
on chronic unpredictable stress induced depression in BALB/c mice 
Azadeh Salehi1, Zahra Rabiei2, Mahbubeh Setorki1,* 
1 Department of Biology, Izeh Branch, Islamic Azad University, Izeh, Iran 
2 Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, 
Shahrekord, Iran 
 
ARTICLE INFO  ABSTRACT 
Keywords: 
Alpinia officinarum 
Extract 
Depression 
Forced swim test 
 Background: Alpinia officinarum is an aromatic plant that show some 
neuroprotective functions in animal models. Objective: This study aimed 
to evaluate the antidepressant effects of hydroalcoholic extract of  
A. officinarum rhizome using two behavioral models. Methods: Forty 
male BALB/c mice were randomized to four groups. All studygroups 
underwent three weeks of daily chronic unpredictable stress (CUS) 
sessions. Control group received daily intraperitoneal (i.p.) injection of 
normal saline 30 min before daily CUS; groups 2, 3 and 4 received i.p. 
injection of 50, 100, and 150 mg/kg/day of A. officinarum extract, 
respectively. Behavior tests were performed after 21 days of treatment. 
Serum and brain malondialdehyde (MDA) and total antioxidant capacity 
(TCA) were also measured. Results: Immobility duration in both forced 
swim test and tail suspension test decreased significantly in the groups 
treated with A. officinarum extract at doses of 50 and 100 mg/kg compared 
to control group (P < 0.05). Extract treatment reduced MDA and increased 
TCA in both brain and serum (P < 0.05). Results demonstrate that the 
hydroalcoholic extract of A. officinarum possesses antidepressant activity 
in the animal model. 
 
1. Introduction 
Depression is one of the most common 
psychiatric disorders that affects more than 300 
million people worldwide [1]. It is considered as 
the mother of many illnesses and can influence 
different aspects of human functioning, including 
occupational, social, and family [2]. Two third of 
patients with depression develop suicidal 
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ideation and around 10-15% of them attempt 
suicide [3]. Studies have shown that distribution 
of monoamine neurotransmission, impairment of 
the hypothalamus-pituitary-adrenal axis, 
neuroinflammatory process, oxidative and 
nitrative stress and also neurodegenerative 
pathway are involved in the pathogenesis of 
depression [4]. Available pharmacotherapies for 
the depression include tricyclic antidepressants, 
selective serotonin reuptake inhibitors, 
monoamine oxidase inhibitors, and certain new 
drugs such as nefazodone and bupropion [5]. All 
available drugs for depression are associated 
with different, sometimes life-threatening, side 
effects; it is therefore necessary to seek out 
effective drugs with the least possible number of 
side effects [6]. 
Plant extracts are one of themost valuable 
sources of novel therapeutic compounds and 
have been shown to produce promising 
antidepressant effects both in animal models and 
clinical studies [2]. Alpinia officinarum, known 
as lesser galangal, is an herbaceous plant in the 
Zingiberaceae family which distributed 
throughout Southeast Asia [7]. A. officinarum 
has a reddish-brown tuberous rhizome with 
anaromatic spicy odor and high pharmaceutical 
and nutritionally value [8]. In Iran, 
A. officinarum rhizome is often used in pickles 
and grinded to be applied in a variety of stews 
and as an aromatic spice [9]. In Iranian traditional 
medicine, it has been suggested to improve 
sexual desire, relief back and sciatica pain, treat 
rheumatic diseases, support immune system 
function and treat digestive disorders and 
stomach pain [10]. Recent studies indicated its 
potential as antioxidant [11, 12], antimicrobial 
[12], anti-inflammatory [13], anticancer [14], 
anti-obesity Hypolipidemic [15] and anti-
diabetic [15] agents. 
Neuroprotective functions of the plant 
rhizome have been also evaluated in some 
studies. Lee et al, reported that A. officinarum 
extract show anti-inflammatory, anti-rheumatic 
and analgesic activities against carrageenan 
induced inflammation and Freund's adjuvant 
(CFA) induced pain and arthritis. It also shows 
anti-psychiatric effects through down regulation 
of c-Fos expression in the hippocampus of CFA-
exposed rats [16]. A diarylheptanoid isolated 
from A. officinarum also demonstrated to show 
neuroprotection against amyloid-β induced 
neural toxicity and damage [17]. Anticholinergic 
effect for the water, ethanol and water/ethanol 
extracts of A. officinarum rhizome was reported 
[11]. Given the useful effects of A. officinarum 
rhizome on the nervous system, we aimed to 
investigate the antidepressant effects the 
hydroalcoholic extract of A. officinarum rhizome 
in mice. 
 
2. Material and Methods 
2.1. Preparation of plant extract 
A. officinarum was purchased from a reliable 
grocery and scientifically and systematically 
approved as A. officinarum; then, 1000 g of its 
dried rhizome was dissolved in 2000 ml of 70% 
ethanol. After the solution was left at room 
temperature for 28 hours, it was filtered and its 
solvent was separated using a rotary evaporator. 
Then, the resulting extract was completely dried 
at room temperature and stored at -20 ºC until use 
[16]. 
 
2.2. Experimental animal and grouping 
Male BALB/cmice weighing 25-30 g were 
used in this study. They were kept in the animal 
house of Islamic Azad University, Izeh Branch, 
at 23 ± 1 ºC under a 12:12 h light-dark cycle with 
ad libitum, constant access to standard water and 
food. The mice were then randomized to foure 
groups of 10 mice. All studies groups underwent 
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three weeks of daily stress sessions. Control 
group received daily i.p. injection of normal 
saline 30 min before the stress session; groups 2, 
3 and 4 received i.p. injection of 50, 100, and 150 
mg/kg/day of A. officinarum extract respectively 
for 21 days [13]. The study was approved by the 
Ethics Committee of Islamic Azad University 
and all animal procedure was based on 
Guidelines for the Care and Use of Laboratory 
Animals [18]. 
 
2.3. Induction of depression through Chronic 
Unpredictable Stress (CUS) 
In this study, depression was induced by CUS 
exposure based on the protocol of Kumar et al 
(Table 1). For this purpose, the mice were daily 
exposed to one of the stressors for 3 weeks, i.e. 
swimming in cold (12 ºC) water for 5 minutes 
(A), swimming at room (23 ± 2 ºC) temperature 
for 10 minutes (A1), swimming at room  
(23 ± 2 ºC) temperature for 15 minutes (A2), 
pressing the tail for 30 seconds (B), pressing the 
tail for 60 seconds (B2), pressing the tail for 90 
seconds (B3), depriving the water and food for 24 
hours (C), keeping waking up overnight, (D), and 
no stress (E) [19]. 
 
Table 1. Exposure of mice to CUS based on the weekly schedule 
weeks Saturday Sunday Monday Tuesday Wednesday Thursday Friday 
1 2A 2B A B C D E 
2 A C A D 3B 1A E 
3 D C D A 2B 2A E 
 
2.4. Forced swim test (FST) 
The forced swim test (FST) is a reliable and 
common test to study the antidepressant-like 
effects of drugs. In this test, a glass cylinder (25 
× 12 × 15 cm) is filled with 25 ºC water and the 
mouse from a 20-cm distance to the water surface 
is slowly placed in the water. Animal is allowed 
to acclimatize for first two minutes. The time of 
immobility was recorded during the last 4 min of 
the 6 min tests. All measurements of variables 
were conducted by one individual [20]. 
 
2.5. Tail suspension test (TST) 
In tail suspension test, metal bars of 70 cm 
high are used with a 50-cm rope longitudinally 
stretched between them. Mouse tail is closed by 
the rope with the mouse hanged up from its tail. 
The test begins with jerking mice. Total duration 
of TST is six minutes, animals were allowed to 
adapt the apparatus for first two minutes. The 
immobility time in the following four minutes 
was counted using a chronometer. All 
measurements of variables were conducted by 
one individual [20]. 
 
2.6. Rotarod test 
The mice were first placed on the rotarod 
roller rod and trained to move on it based on the 
main protocol (speed: 10 rpm and acceleration: 7 
rpm2), and the balance test was performed 30 min 
later. All mice were placed on the rotarod 1 h 
after injection of the extract. The period when 
mouse could maintain its balance and resist 
against the movement of the rotarod was 
considered resistance time. The maximum test 
time for each mouse was considered 300 seconds 
[20]. 
 
2.7. Measurement of lipid peroxide levels in 
serum and brain tissues 
200 μl of tissue homogenate/ serum was 
mixed with 1.5 ml of 20 % acetic acid, 1.5 ml of 
0.8 % TBA and 200 μl of 8.1 % SDS. The 
mixture was made up to 4 ml with distilled water 
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and heated in a boiling water bath for 60 minutes. 
After cooling under tap water, 1 ml of distilled 
water and 5 ml of n-butanol/pyridine were added 
to the reaction mixtures and shaken vigorously. 
Then, the resulting solutions were centrifuged at 
4000 rpm for 10 min and the optical absorbance 
of the supernatant at 532 nm was recorded. Lipid 
peroxide levels were determined using standard 
calibration curve and expressed as a micromol of 
malondialdehyde [20]. 
 
2.8. Measurement of total antioxidant capacityin 
serum and brain tissues 
Antioxidant capacity of serum and tissue 
homogenate was measured by using ferric 
reducing antioxidant power (FRAP) assay. The 
working FRAP reagent was prepared by mixing 
10 ml of 0.25 M acetate buffer (pH 3.6), 2.5 ml 
of 10 mM TPTZ in 40 mM HCl and 2.5 ml of  
20 mM FeCl3.6H2O. 25 µl of tissue 
homogenate/serum were added to 1.5 ml of 
working FRAP solution and left at 37 ºC for 10 
minutes. After incubation, the optical absorbance 
at 593 nm was recorded [20]. 
 
2.9. Statistical analysis 
Data were analyzed using SPSS version 20. 
Analysis of Variance (ANOVA) followed by 
Duncan’s test used to identify statistical 
differences between means. All data were 
presented as mean ± SD and p value less than 
0.05 was considered statistically significant. 
 
3. Results 
Results demonstrated that 50 and 100 mg/kg 
body weight (BW) of A. officinarum extract 
could significantly decrease the immobility 
duration in forced swim test (FST) compared to 
normal saline (control group) (P < 0.001 and  
P < 0.05, Fig. 1). 
According to our results, 50 and 100 mg/kg 
BW of A. officinarum extract could significantly 
decrease the immobility duration in tail 
suspension test (TST) compared to control group 
(P < 0.001 and P < 0.05, Fig. 2). 
 
 
 
Fig. 1. Immobility duration in forced swim test in different groups; * shows significant differences with control 
group (*P < 0.05 and ***P < 0.001). AP: Alpinia officinarum 
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Fig. 2. Immobility duration in tail suspension test in different groups; * shows significant differences with control 
group (**P < 0.01 and ***P < 0.001). AP: Alpinia officinarum 
 
According to our results, in rotarod test 
there was no significant difference between 
the experimental groups (P > 0.05, Fig 3). 
In this study, we observed that 50, 100, and 
150 mg/kg BW of A. officinarum extract could 
significantly increase serum and brain ferric 
reducing antioxidant power (FRAP) (P < 0.05, 
Fig. 4). 
Results also demonstrated that all doses of  
A. officinarum extract significantly decrease 
malondialdehyde (MDA) levels in serum of 
experimental groups compared to control group 
(P < 0.003, Fig. 5). Brain MDA level showed 
significant reduction only in group treated with 
150 mg/kg BW of A. officinarum extract  
(P < 0.001). (P < 0.05, Fig. 5). 
 
 
Fig. 3. Duration of time to maintain balance on the rotating rod of rotarod in different groups. AP: Alpinia officinarum 
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Fig. 4. Comparison of serum and brain ferric reducing antioxidant power (FRAP) among groups; * shows 
significant differences with control group (*P < 0.05, **P < 0.01 and ***P < 0.001); AP: Alpinia officinarum. 
 
 
Fig. 5. Comparison of serum and brain malondialdehyde levels among groups; * shows significant differences with 
control group (***P < 0.001); AP: Alpinia officinarum. 
 
4. Discussion 
In the present study, the effects of 50, 100, and 
150 mg/kg BW of A. officinarum extract on 
symptoms of CUS-induced depression in mouse 
model were investigated. Besides that, the effects 
of A. officinarum extract on MDA and TCA 
levels in both serum and brain of CUS treated 
mice were examined. Results demonstrated that 
the immobility duration in the FST and the TST 
were significantly longer in the group under CUS 
than other groups; and A. officinarum extract 
could significantly decrease the immobility 
duration in the mice. It was also found that as the 
dose of the extract increased, its antidepressant 
effects decreased, reinforcing the possibility that 
the observed effects may be due to the non-
pharmacological and possibly toxic effects of the 
extract. 
In our study, treatment of mice with  
A. officinarum extract significantly inhibited 
chronic stress induced lipid peroxidation in both 
brain and serum and improved their antioxidant 
capacity. The role of oxidative stress in CUS-
induced depression has been reported by a 
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number of studies. CUS is associated with 
decreased superoxide dismutase (SOD) and 
glutathione reductase activities and reduced 
glutathione level in rat brain [21]. In addition, 
chronic stress causes significant decrease in 
glutathione peroxidase (GPX) activity, 
glutathione content and vitamin C level of brain 
and increases its lipids peroxidation [22]. 
Increased protein and lipids peroxidation and 
reduced SOD activity in the different brain 
regions of CUS-exposed mouse [23]. CUS-
induced depression led to decrease in antioxidant 
capacity and the activity of GPX, SOD, and 
catalase in the hippocampus and hypothalamus 
[24]. So, the antidepressant-like activity 
observed for A. officinarum extract in our study, 
may be related to its antioxidant action and 
inhibition of oxidative stress marker in both brain 
and serum. Our results also demonstrated that A. 
officinarum extract significantly decrease 
malondialdehyde (MDA) levels in serum and 
brain in animals. A. officinarum extract could 
significantly increase serum and brain total 
antioxidant capacity. 
Aqueous, ethanolic, and hydroalcoholic 
extracts of A. officinarum rhizome displayed 
significant antioxidant activity in inhibiting the 
ABTS [2,2′-azinobis-(3-ethylbenzothiazoline-6-
sulfonic acid)], DPPH (1,1-diphenyl-2-
picrylhydrazyl), superoxide radicals and 
hydrogen peroxide. These extracts also showed 
significant effects in chelating and reducing iron 
and copper ions [11]. Galangin, the main 
flavonoid compound in A. officinarum rhizome, 
significantly prevented D-galactose induced 
memory loss and passive avoidance memory. 
They argued that galangin exerts protective 
effects on the central nervous system via 
decreasing oxidative stress parameters [25]. 
Studies suggest that neuroinflammatory 
process following chronic stress has potential 
mechanistic role in the development of 
depressive-like behavior. A study showed that 
exposure to CUS caused increase in serum tumor 
necrosis factor alpha (TNFα) level in mouse 
brain [21]. The expression of proinflammatory 
cytokines (TNFα, interleukin 6 (IL-6), and 
interleukin 1 beta (IL-1β)) significantly 
increased in the brain and spleen of the mice 
under chronic stress, and the expression of anti-
inflammatory cytokines (transforming growth 
factor beta (TGF-β) and interleukin 10 (Il-10)) 
significantly decreased in these mice [26]. 
Chronic stress-induced depression increased the 
levels of the inflammatory markers IL-6 and 
TNF-α [24]. It was reported that celecoxib, an 
anti-inflammatory drug, shows therapeutic 
effects on major depression in clinical trial [27]. 
A. officinarum is a medicinal plant known for 
anti-inflammatory properties. Traditionally it is 
recommended to treat and alleviate the 
symptoms of rheumatic diseases and other 
inflammatory conditions [10]. The anti-
inflammatory effects of A. officinarum extract 
have been examined in a number of studies.  
A. officinarum extract significantly decrease 
slipopolysaccharide induced nitric oxide 
generation in mouse macrophage cell and 
inflammatory cytokines (IL-1β and TNFα) 
production in human peripheral blood 
mononuclear cells [13]. Lee et al. study showed 
that ethanolic extract of A. officinarum rhizome 
ameliorate inflammatory response in 
carrageenan-treated tars [16]. It has been 
reported that the galangin found in A. officinarum 
rhizome exerts anti-inflammatory effects [28]. 
The Rotarod test was to confirm that the 
animals had no motor impairment and were not 
in the forced swimming and tail suspension test 
immobility was not due to a motor problem. 
Results demonstrate that the hydroalcoholic 
extract of A. officinarum possesses 
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antidepressant activity in the animal model. The 
antidepressant activity observed for  
A. officinarum extract may be related to the 
suppression of inflammatory responses and 
oxidative stress markers. 
 
5. Conclusion 
Administration of depressed mice with  
A. officinarum extract caused antidepressant effects 
and significantly increased the immobility duration 
in the FST and TST. In the current study, A. 
officinarum extract at different concentrations 
caused significant increase in the antioxidant 
capacity and significant decrease in the brain and 
serum MDA levels. It seems that the antidepressant 
effects of this extract are due to antioxidant and anti-
inflammatory mechanisms. 
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 مقاله تحقیقاتی
بر افسردگی ناشی از استرس غیرقابل  گیاه خولنجان اثرات ضد افسردگی عصاره هیدروالکلی ریزوم
 BALB/cبینی در موش پیش
 *،1، محبوبه سترکی2زهرا ربیعی، 1آزاده صالحی
 ایذه، ایرانشناسی، واحد ایذه، دانشگاه آزاد اسالمی، گروه زیست 1
 ، ایرانتحقیقات گیاهان دارویی، پژوهشکده علوم پایه سالمت، دانشگاه علوم پزشکی شهرکرد مرکز 2
 چکیده  اطالعات مقاله
 :واژگانگل
 خولنجان
 عصاره
 افسردگی
 تست شنای اجباری
های کننده عصبی را در مدلیک گیاه معطر است که برخی از عملکردهای محافظت خولنجان :مقدمه 
ریزوم  هدف این مطالعه ارزیابی اثرات ضد افسردگی عصاره هیدروالکلی هدف:دهد. حیوانی نشان می
در چهار گروه  BALB/cموش نر  40 :روش بررسیباشد. با استفاده از دو مدل رفتاری میخولنجان 
بینی مزمن تحت استرس غیرقابل پیشروزانه های مطالعه سه هفته تصادفی قرار گرفتند. همه گروه
(CUSقرار گرفتند. گروه کنترل روزانه از طریق تزریق داخل صفاقی ) (i.p )30  دقیقه قبل ازCUS 
گرم / میلی 150و  100، 50به ترتیب  i.p به روش 4و  3، 2های نرمال سالین دریافت کردند. گروه
ز درمان انجام شد. رو 21های رفتاری پس از دریافت کردند. تست خولنجانکیلوگرم در روز عصاره 
 :نتایجگیری شد. ( نیز اندازهTCAاکسیدان کل )مغز و سرم و ظرفیت آنتی (MDAمالون دی آلدهید )
های تحت درمان با عصاره مدت زمان تحرک در هر دو تست شنا اجباری و تست تعلیق دم در گروه
داری کاهش به طور معنی گرم بر کیلوگرم نسبت به گروه کنترلمیلی 100و  50در دوزهای  خولنجان
. (> 05/0P)در مغز و سرم شد  TCAو افزایش  MDA. تیمار عصاره باعث کاهش ( > 05/0P)یافت 
نی دارای فعالیت ضد افسردگی در مدل حیوا خولنجاننتایج نشان داد که عصاره هیدروالکلی  گیري:نتیجه
 است.
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